Bioequivalence and Bioavailability Forum

Hi all,

I’m looking for clarification on ANVISA’s regulations regarding participant eligibility for clinical trials, particularly:

Are there restrictions, such as a required gap (e.g., 180 days) after participation in another trial or blood donation?
Where can I find this information in ANVISA’s guidelines?
What’s the best way to contact ANVISA for further clarification?
Any specific references or insights would be greatly appreciated!

Thanks!